Finance

Lists
COH:ASX
Cochlear Ltd
A$142.74
+1.26%
(+1.77) 1D
Sep 4, 4:10:25 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for COH...
Open
A$140.00
High
A$145.78
Low
A$140.00
Mkt. cap
9.34B
Avg. vol.
723.25K
Volume
657.16K
Dividend
2.42%
Quarterly dividend
A$0.86
Ex-dividend date
Sep 21, 2026
P/E ratio
63.51
52-wk high
A$303.74
52-wk low
A$88.74
EPS
A$2.25
Shares outstanding
65.40M
No. of employees
5K
Open
A$140.00
High
A$145.78
Low
A$140.00
Mkt. cap
9.34B
Avg. vol.
723.25K
Volume
657.16K
Dividend
2.42%
Quarterly dividend
A$0.86
Ex-dividend date
Sep 21, 2026
P/E ratio
63.51
52-wk high
A$303.74
52-wk low
A$88.74
EPS
A$2.25
Shares outstanding
65.40M
No. of employees
5K
News stories
From web sources and news partners
Profile
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant. Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015. Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. Wikipedia
About Cochlear Ltd
CEODig Howitt
Employees5.4K
Founded1981
HeadquartersSydney, New South Wales, Australia
SectorMedical device
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
583.60M
583.60M
590.20M
590.20M
Cost of goods sold
159.60M
159.60M
184.40M
184.40M
Cost of revenue
159.60M
159.60M
184.40M
184.40M
Research and development expenses
76.40M
76.40M
85.20M
85.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
224.70M
224.70M
239.40M
239.40M
Operating expense
297.85M
297.85M
321.20M
321.20M
Total operating expenses
457.45M
457.45M
505.60M
505.60M
Operating income
126.15M
126.15M
84.60M
84.60M
Other non operating income
-
-
-
-
EBT including unusual items
106.55M
106.55M
400.00K
400.00K
EBT excluding unusual items
128.25M
128.25M
86.55M
86.55M
Income tax expense
25.80M
25.80M
7.50M
7.50M
Effective tax rate
24.21%
24.21%
1,875.00%
1,875.00%
Other operating expenses
-3.25M
-3.25M
-3.40M
-3.40M
Net income
80.75M
80.75M
-7.10M
-7.10M
Net profit margin
13.84%
13.84%
-1.20%
-1.20%
Earnings per share
-
-
-
-
Interest and investment income
4.20M
4.20M
900.00K
900.00K
Interest expense
-3.15M
-3.15M
-3.45M
-3.45M
Net interest expenses
1.05M
1.05M
-2.55M
-2.55M
Depreciation and amortization charges
-
-
-
-
EBITDA
151.95M
151.95M
88.00M
88.00M
Gain or loss from assets sale
-
-
5.80M
5.80M
AI content may include mistakes. Learn more
Google apps